16-2085322-G-C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_000548.5(TSC2):āc.4662G>Cā(p.Gln1554His) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1554P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000548.5 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TSC2 | NM_000548.5 | c.4662G>C | p.Gln1554His | missense_variant, splice_region_variant | Exon 36 of 42 | ENST00000219476.9 | NP_000539.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSC2 | ENST00000219476.9 | c.4662G>C | p.Gln1554His | missense_variant, splice_region_variant | Exon 36 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
TSC2-related disorder Uncertain:1
The TSC2 c.4662G>C variant is predicted to result in the amino acid substitution p.Gln1554His. This variant occurs at the final nucleotide position of exon 36 and splicing prediction programs predict a splicing defect at the consensus donor site (SpliceAI, Jaganathan K, et al. 2019. PubMed ID: 30661751). This variant was reported as probably pathogenic in an individual with suspected tuberous sclerosis complex (TSC); however, detailed clinical information was not provided (Table S2, Hoogeveen-Westerveld et al. 2013. PubMed ID: 22903760). In addition, functional analyses of this variant showed that it led to an increased but "intermediate" effect when compared to wild type and a known pathogenic TSC2 variant (Table S1, Hoogeveen-Westerveld et al. 2013. PubMed ID: 22903760). This variant has not been reported in large population database, indicating this variant is rare. Of note, a different nucleotide variant (c.4662G>T) leading to the same amino acid change (p. Gln1554His) was reported as de novo in a patient with TSC (Rendtorff et al. 2005. PubMed ID: 16114042). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Tuberous sclerosis syndrome Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at